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Graphical Abstract 
 
Highlights 
 Biocatalysts for prochiral heterocyclic ketone reduction were selected by screening 
 E. chrysanthemi and M. racemosus almost quantitatively reduced cyclododecanone. 
 E. carotovora produced (S)-N-Boc-3-pyrrolidinol with 87% yield and 99%ee.  
 X. fragariae produced (S)-1-phenylethanol with 100% yield and 79%ee. 
 G. candidum produced (R)-1-phenylethanol with 55% yield and 93%ee. 
Abstract 
The reduction of carbonyl compounds plays an important role in the synthesis of complex chiral molecules. In 
particular, enantiopure substituted cyclic and heterocyclic compounds are useful intermediates for the synthesis of 
several antiviral, antitumor, and antibiotic agents, and recently, they have also been used as organocatalysts for C-
C addition. Alcohol dehydrogenases (ADH) are enzymes involved in the transformation of prochiral ketones to chiral 
hydroxyl compounds. While significant scientific effort has been paid to the use of aliphatic and exocyclic ketones 
as ADH substrates, reports on (hetero)cyclic carbonyl compounds as substrates of these enzymes are scarce. In 
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the present study, 109 bacteria and 36 fungi were screened, resulting in 10 organisms belonging to both kingdoms 
capable of transforming cyclic and heterocyclic ketones into the corresponding alcohols. Among them, Erwinia 
chrysanthemi could quantitatively reduce cyclododecanone and Geotrichum candidum could stereoselectively 
reduce N-Boc-3-piperidone and N-Boc-3-pyrrolidinone to their corresponding (S)-alcohols; however, the anti-Prelog 
isomer was obtained when acetophenone was the substrate. 
Keywords: alcohol dehydrogenases; (hetero)cyclic ketones; microbial reduction; hierarchical screening 
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1. Introduction 
Cyclic and heterocyclic scaffolds are frequently present in many natural and unnatural products with important 
biological activity, in synthetic intermediates used for the synthesis of many drugs, and in reagents and additives 
used in different industries [1, 2]. For example, pyrane ring is present in zanamivir, an antiviral drug approved for 
treatment of influenza [3], and polyhydroxylated piperidines are a class of azasugars called iminocyclitols, which 
are carbohydrate mimetics used as glycosidase inhibitors [4]. Piperidinols have also been identified as potential 
antimycobacterial agents that inhibit mycobacterial arylamine N-acetyltransferase, an enzyme recognized as the 
potential target for the treatment of tuberculosis [5]. Heteronucleosides are compounds in which the oxygen in the 
carbohydrate moiety is replaced by sulfur, nitrogen, and more recently by selenium and have received much 
attention because of their therapeutic applications. Among them, thiarabine is a potent antitumor agent, and 
lamivudine was approved for the treatment of HIV infection [6]. Regarding azanucleosides, five-membered 
pyrrolidine-type azanucleosides have been the most investigated because of their similarity with naturally occurring 
nucleosides [7]. 
Consequently, great effort has been made for designing efficient strategies to prepare substituted heterocyclic 
compounds [8]. Among them, the reduction of carbonyl compounds plays an important role because the reduction 
of prochiral ketones to chiral alcohols is an excellent way to generate chirality in the synthesis of a molecule. In 
addition, the enantiomerically pure alcohol can be easily transformed into other useful functional groups without 
racemization. Whereas traditional synthetic methods predominantly use toxic metals and expensive complex 
hydrides [9], biotransformations offer significant advantages for the green and sustainable manufacturing of 
chemicals. In particular, biocatalysis becomes a preferred approach for asymmetric synthesis because of its 
excellent chemo-, regio-, and stereoselectivity [10].  
Alcohol dehydrogenases (ADHs) [11] and ketone reductases [12], classified under E.C.1.1.X., are enzymes that 
catalyze the reversible reduction of the carbonyl group. To exhibit catalytic activity, these enzymes require 
nicotinamide cofactors such as NADH or NADPH. Many dehydrogenases/reductases reduce prochiral ketones 
following the Prelog rule, in which the hydride ion of NAD(P)H is transferred to the re-face of ketones, yielding chiral 
alcohols with (S)-configuration. Anti-Prelog stereoselectivity is uncommon in nature, and the majority of these 
enzymes are NADPH dependent [13]. Because NADH is much cheaper and more stable than NADPH under 
operational conditions, NADH-dependent anti-Prelog enzymes are frequently required for practical applications [14]. 
 5 
Microbial transformations using bacteria or fungi as catalysts have been known for many decades. The use of 
microbial whole cells is economically advantageous as isolated enzymes [15] involve costly enzyme purification 
and recycling system for expensive coenzymes. Moreover, the use of whole-cell biocatalysts is, in most cases, 
more desirable for minimizing downstream processing [16]. In particular, yeasts have been applied in biocatalytic 
redox processes, being G. candidum and Saccharomyces cerevisiae workhorses in asymmetric ketone 
transformations [17]. 
Although some biocatalysts have been reported for the reduction of carbocyclic ketones [18], little attention has 
been devoted to substrates containing heteroatoms. In this regard, stereoselective HLADH-catalyzed 
biotransformations of 2-substituted tetrahydropyran-4-ones into trans tetrahydropyran-4-ols has been reported [19]; 
Daucus carota was used to reduce N-Boc-piperidin-3-one to (S)-N-Boc-3-hydroxypiperidine with 95% optical purity 
but low yield [20]; and Ju et al. [21] reported an efficient process for the same substrate but catalyzed by a 
recombinant ketoreductase with >99%ee. 
Five-membered heterocyclic ketones are difficult to reduce in a stereoselective manner, and the majority of the 
assayed wild type biocatalysts have failed in this purpose [22]. (R)-Tetrahydrothiophene-3-ol, a key intermediate in 
the synthesis of penem-based antibiotics [23], has been prepared with high selectivity, starting from 
tetrahydrothiophene-3-one using mainly Penicillium, Aspergillus, or Streptomyces strains [24]. Optically active 3-
pyrrolidinol derivatives are also versatile building blocks for the synthesis of pharmaceuticals such as quinolones, 
β-lactam antimicrobial agents, and calcium antagonists. Devosia riboflavin (KNK10702) was discovered when it 
was screened for the stereoselective reduction of N-benzyl-3-pyrrolidinone and piperidinone to the (R)-alcohol, 
while (S)-N-benzyl-3-pyrrolidinol was purified and characterized from G. capitatum (JCM3908) [25]. Recently, 
directed evolution was applied to TbSADH, an ADH from Thermoethanolicus brockii, and (R)- and (S)-selective 
variants for the reduction of tetrahydrofuran-3-one and tetrahydrothiofuran-3-one were obtained (95-99%ee) [22]. 
Using these recombinant enzymes, Boc-protected N-analogs were reduced only to the (S)-isomer.  
Screening of wild-type microorganism collections remains one of the most powerful tools for finding novel 
biocatalytic reduction systems. Therefore, the aim of the present work was to select new sources of useful 
biocatalysts for the synthesis of cyclic and heterocyclic alcohols. 
2. Materials and Methods 
2.1. Chemicals and microorganisms 
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Cyclohexanone, tetrahydro-4H-pyran-4-one, tetrahydro-4H-thiopyran-4-one, N-Boc-4-piperidinone, 
cyclododecanone, N-Boc-3-piperidinone, N-Boc-3-pyrrolidinone, and acetophenone were purchased from Sigma-
Aldrich (St Louis, MO, USA). All other chemical reagents used were commercially available and of the best analytical 
grade. 
The culture media components were obtained from Britania (CABA, Argentina) or Biopack (Zárate, Argentina). 
HPLC-grade methanol and acetonitrile were from Carlo Erba (Rodano, Italy) or Sintorgan (Buenos Aires, Argentina). 
Bacteria were supplied by the Colección Española de Cultivos Tipo (CECT), Universidad de Valencia (Spain). Fungi 
were kindly provided by the Food Mycology Laboratory, Universidad Nacional de Quilmes (Argentina). 
2.2. Standard growth conditions 
2.2.1. Bacterial strains 
Bacterial strains were cultured in 25 mL flasks containing 5 mL liquid media at the optimum temperature (T) and 
time (t), according to the American Type Culture Collection (ATCC) (see Supplementary material). Growth was 
measured by determining the optical density at 600 nm (DO600 nm, equivalence: 0.4 DO units: 2x108 cells mL-1).  
2.2.2. Fungal strains  
Fungal strains were cultured on solid media at the optimal temperature (T) and time (t), according to ATCC (see 
Supplementary material). After growth in Petri dishes, 25 mL flasks containing 5 mL of the corresponding liquid 
media were inoculated with 1x104 spores mL-1 (counted on a Neubauer chamber), and the cultures were incubated 
at 26°C for 3-6 days. 
2.3. Identification of G. candidum fungal strain 
2.3.1. Fungal material 
G. candidum strain GC1, isolated from dairy products in Santa Fe province, Argentina, was maintained in laboratory 
on 2% malt extract agar at 23°C. The original species of the strain was identified on the basis of its physio-
morphological growth characteristics.  
2.3.2. Genomic DNA extraction 
Genomic DNA of G. candidum strain GC1 was extracted from mycelia grown on 2% malt extract agar at 23ºC for 1 
week. Hundred milligrams of mycelia was frozen in liquid nitrogen and pulverized by grounding with mortar and 
pestle, and total gDNA was purified using DNAeasy plant mini kit (Quigen, Hilden, Germany) according to the 
manufacturer’s instruction. The gDNA yield was quantified on NanoDrop 1000 spectrophotometer (Termo Fisher 
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Scientific Inc.), and the sample integrity was evaluated by electrophoretic size separation on 1% agarose gel with 
posterior ethidium bromide staining. 
2.3.3. PCR amplification of nuclear ribosomal DNA 
Five nanograms of total gDNA was used as template for the PCR amplification of genomic rRNA encoding locus 
with the universal fungal internal transcribed spacer (ITS) region primers ITS1 and ITS4 (5´-
TCCGTAGGTGAACCTGCGG-3´/5´-TCCTCCGCTTATTGATATGC-3´ [26]). The given primer pair amplifies from 
the 3’ of the ribosomal small subunit 18S rDNA till the 5´of the large subunit 28S rDNA. The resultant amplicon 
includes sequences ITS1, rDNA of 5.8S, and ITS2.  
The PCR reaction final volume of 20 µL included 1x Taq buffer with (NH4)2SO4, 1 µM of each primer, 1.5 mM MgCl2, 
200 µM each of four dNTPs, and 1 U of Taq DNA polymerase. The PCR was done using  products of Fermentas 
(TermoFisher Scientific Inc) and the primers were purchased from Genbiotech, Argentina.  
The PCR conditions were as follows: initial denaturation for 5 min at 95°C, 30 cycles of denaturation at 95°C for 15 
s, annealing at 55°C for 30 s, and elongation at 72°C for 1 min, followed by a final elongation at 72°C for 7 min. The 
amplification was performed on Tpersonal thermocycler (Biometra®), and the results of PCR were analyzed by 
electrophoretic separation on 1% agarose gel and visualized with ethidium bromide staining. 
2.3.4. Sequencing and analysis of rDNA-ITS amplicon 
The PCR reactions presented a single specific amplification product of approximately 400 bp. The amplicon was 
purified directly from the PCR reaction mixtures using MinElute PCR Purification Kit (Qiagen, Hilden, Germany) and 
sequencing was performed by the Sanger dideoxy sequencing method using both ITS1 and ITS4 as sequencing 
primers. Sequencing service was purchased from Macrogen (Seoul, South Korea). The PCR amplicon was 
sequenced four times in total, twice from both sequence directions.  
The raw sequencing chromatograms were evaluated manually to identify reliable base calling regions and checked 
for possible ambiguous bases. The trimmed two forward and two reverse sequences were aligned to construct the 
final 372bp long rDNA-ITS sequence using Clustal Omega online aligning platform 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). The final sequence was deposited in GenBank under accession no. 
KY009607. The species identity of the fungal strain GC1 was evaluated based on BLAST searches of the rDNA-
ITS sequence against public nucleotide collections (nt/nr) using megablast search option 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). 
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2.4. Bacterial screening 
2.4.1. Primary Screening  
The 109 bacterial strains were cultured in minimal medium (13.6 g/L KH2PO4; 2.5 g/L (NH4)2SO4; 0.3 g/L MgSO4; 
0.5 mg/L FeSO4.7H2O; 5 mg/L citric acid; 5 mg/L ZnSO4.7H2O; 1 mg/L Fe(NH4)2(SO4)2; 0.25 mg/L CuSO4.5H2O; 
0.05 mg/L MnSO4.H2O; 0.05 mg/L H3BO3 anhydrous; 0.065 mg/L (NH4)2MoO4; 0.4 µM biotin; 30 µM thiamine-HCl; 
20 µM calcium pantothenate; 26 µM riboflavin; 23 µM folic acid) containing L-tyrosine (0.4 g/L) or L-phenylalanine 
(0.4 g/L) as the sole carbon and energy source at the optimal temperature of each microorganism. Culture growth 
was determined by measuring DO600 nm every 24 h for 144 h. 
2.4.2. Secondary screening  
The strains selected in the primary screening were used to perform a colorimetric assay to identify ADH activity in 
the corresponding cell extracts [27]. After growing the microorganisms in their optimal medium, treating the cells 
with lysozyme (1 mg/mL) and DNAse (1 U/mL), and centrifugation, the obtained supernatants were mixed with 
NAD+ or NADP+ (225 µM), nitroblue tetrazolium chloride (NBT, 225 µM), phenazine methosulfate (PMS, 22.5 µM), 
gelatin (0.13% w/w), and cyclohexanol (225 µM) in 50 mM Tris-HCl buffer, pH 8, at 30C. Different volumes of cell 
lysates were assayed, which correspond to different concentrations of total proteins in the reaction medium: 0.05, 
0.1, 0.15, and 0.2 mg/mL. The reaction was followed spectrophotometrically ( = 508 nm) in 96-well microtiter plates 
by monitoring the production of formazan at 1, 24, and 48 h.  
2.4.3. Specific Screening  
The strains selected in the secondary screening were used as biocatalysts in liquid medium for the reduction of 
cyclic ketones using cyclohexanone as a model substrate by adapting a methodology previously reported [28]. The 
microorganisms were cultured as mentioned above (see standard growth conditions), and then cyclohexanone (10 
mM) was added. The reaction was carried out at 30ºC in an orbital shaker at 180 rpm for 2 days. After removing 
the cells by centrifugation, the supernatants were extracted using ethyl acetate or diethyl ether, and the organic 
layers were analyzed by Gas Chromatography (GC). 
2.5. Fungal Screening 
Fungal strains were cultured as detailed in Standard Growth Conditions. After 6 days, cyclohexanone (10 mM) was 
added, and the reaction was carried out at 26ºC in an orbital shaker at 180 rpm for 4 days. After removing the cells 
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by filtration, the supernatants were extracted using ethyl acetate or diethyl ether. The organic layers were analyzed 
by GC.  
2.6. Standard biotransformation 
The selected strains were used as biocatalysts for the reduction of tetrahydro-4H-pyran-4-one, tetrahydro-4H-
thiopyran-4-one, N-Boc-4-piperidinone, cyclododecanone, N-Boc-3-piperidinone, N-Boc-3-pyrrolidinone, and 
acetophenone using the same experimental conditions as mentioned in Specific Screening.  
2.7. Analytical methods 
Qualitative analysis was performed by Thin Layer Chromatography using Silicagel 60 F254 plates (Merck, Rahway, 
NJ, USA) and 9.0/1.0 (v/v) CH2Cl2/CH3OH as mobile phase. Rf: cyclohexanone 0.94, cyclohexanol 0.8, tetrahydro-
4H-thiopyran-4-one 0.82, tetrahydrothiopyran-4-ol 0.62, tetrahydro-4H-pyran-4-one 0.83, tetrahydro-4-pyranol 
0.49, N-Boc-4-piperidinone 0.86, N-Boc-4-piperidinol 0.6, cyclododecanone 0.73, cyclododecanol 0.67, N-Boc-3-
piperidinone 0.8, N-Boc-3-piperidinol 0.6, N-Boc-3-pyrrolidinone 0.89, N-Boc-3-pyrrolidinol 0.62, acetophenone 
0.85, and 1-phenylethanol 0.31. 
GC analysis was performed using an Agilent 7890B GC with an Agilent 5977A series GC/MSD and a HP-5MS UI 
(30 m x 0.25 mm, 0.25 µm) column. The operating conditions were as follows: injector temperature 250ºC; 5 min at 
50ºC and 20ºC/min gradient to 280ºC, run time: 16.5 min. MSD: full SCAN: 40-500, injection volume 1 µL, split: 
1:50, heaters: 280ºC. Rt (min): cyclohexanone 5.8; cyclohexanol 6.1; tetrahydro-4H-thiopyran-4-one 9.1; 
tetrahydrothiopyran-4-ol 9.6; tetrahydro-4H-pyran-4-one 6.5; tetrahydro-4-pyranol 7.3; N-Boc-4-piperidone 12.1; N-
Boc-4-piperidinol 12.4; cyclododecanone 12.8, cyclododecanol 13, N-Boc-3-piperidone 12.3, N-Boc-3-piperidinol 
12.2, N-Boc-3-pyrrolididone 12, and N-Boc-3-pyrrolidinol 12.1. 
High-Performance Liquid Chromatography (HPLC) analysis was performed using a Beckman SystemGold HLPC 
with UV detector and a GraceSmart RP18 4.6 mm x 150 mm, 5 µm particle size column. The operating conditions 
were as follows: flow 0.9 mL/min, 5 min acetonitrile:water 45:55, 3%/min gradient to acetonitrile:water 80:20, 5 min 
acetonitrile:water 80:20, run time 22 min, detection λ=245 nm. Rt (min): acetophenone 3.7 and 1-phenylethanol 
15.6. 
Chiral GC analysis was performed using a Shimadzu GCMS-QP2010 plus with Supelco BetaDEX TM 325 30 m x 
0.25 mm x 0.25 µm column. The operating conditions were as follows: (a) injector temperature 220ºC, 5 min at 
60ºC, 4ºC/min gradient to 150ºC and 30ºC/min gradient to 220ºC column temperature, run time: 31.00 min. Injection 
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volume 1 µL. Rt (min): acetophenone 18.5, (S)-1-phenylethanol 21.7, and (R)-1-phenylethanol 22.0 and (b) injector 
temperature 220ºC, 5 min at 60ºC, 1ºC/min gradient to 140ºC column temperature, run time: 88.00 min. Injection 
volume 1 µL. Rt (min): N-Boc-3-piperidinone 71.3, (S)-N-Boc-3-piperidinol 85.0, (R)-N-Boc-3-piperidinol 85.5, N-
Boc-3-pyrrolidinone 50.6, (S)-N-Boc-3-pyrrolidinol 51.8, and (R)-N-Boc-3-pyrrolidinol 52. 
3. Results and discussion 
The development of different and accurate screening techniques is one of the most important steps toward detection 
of new biocatalysts. Although the fastest and easiest route to find a new enzyme is to identify one that exists in 
commercial libraries, they can have limited diversity and may be economically inaccessible. On the contrary, 
sources such as microbial collections or gene libraries [29] are readily available and have the advantage of enabling 
the discovery of unknown enzymes.  
3.1. Bacterial screening 
In this regard, to find enzymes than can reduce cyclic and heterocyclic ketones, we decided to perform a hierarchical 
screening procedure using our bacterial collection. This three-step screening consisted of a primary growth 
selection step on amino acids as the sole energy source, a second step using colorimetric assay for cyclohexanol 
oxidation, and a third step involving the reduction of cyclohexanone as a model reaction (Fig. 1). 
3.1.1. Primary screening 
The first selection of microorganisms possibly containing redox enzymes was conducted by culturing the bacterial 
strains in the presence of L-phenylalanine or L-tyrosine as the sole carbon and energy source. The degradation 
pathways of these amino acids are known to involve several oxidoreductases, including some dehydrogenases [30, 
31]. Therefore, we expected to find microorganisms that can grow either in the presence of one or both tested amino 
acids, depending on the endogenic enzyme repertoire of each microorganism. For practical purposes, growth was 
considered positive when DO600 nm was higher than 0.3. From the 109 bacterial species tested, 16 grew only on 
tyrosine, 15 only on phenylalanine, and 38 on both amino acids (Table S1 in Supplementary material). The natural 
activity of the majority of the microorganisms selected in this primary screening is the degradation of organic matter 
and soil detoxification, which agrees with the target enzymatic activity.  
3.1.2. Secondary screening  
Different methodologies for the detection of ADHs using their natural oxidation activity have been reported, including 
spectrophotometric [32] and colorimetric strategies using tetrazolium salts [26] or p-rosaniline [33]. In the present 
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work, to obtain a rapid and simple detection of bacterial ADHs, the NAD(P)H produced by the oxidation of 
cyclohexanol to the corresponding ketone was detected by a colorimetric assay on the basis of its reaction with 
NBT in the presence of PMS [27] (Fig. S2 in Supplementary material). The formation of Formazan, the blue-purple 
product of the reaction, was colorimetrically determined at 580 nm. This methodology has already been used to 
detect several dehydrogenases such as lactic [34] and 3-β-hydroxy-5-steroid [35] dehydrogenases from different 
biological sources including mammals, bacteria, fungi, and plants. However, to our knowledge, this assay has not 
been applied before on wild-type bacterial ADHs using cyclic alcohols as enzyme substrates. 
Our secondary screening revealed that 38 of the tested bacteria could oxidize cyclohexanol to cyclohexanone. Eight 
of these depended only on NAD+, four on NADP+, and the remaining 26 showed no cofactor specificity. This NAD+ 
or NADP+ dependence is a useful variable that can be considered for future reaction scaling up. In addition, we 
evaluated the effect of the reaction time and the cell concentration on the oxidization of cyclohexanol to 
cyclohexanone. Regarding reaction time, E. carotovora (CECT 225) oxidized cyclohexanol after 1 h with the lowest 
cell extract amount, while the rest of the bacteria performed the biotransformation after 24 h and/or at higher 
quantities of biocatalyst. Detailed results of the secondary screening are available in Table S1, Supplementary 
material. 
3.1.3. Specific screening 
Finally, cyclohexanone was used as substrate for the bacteria selected based on the previous two screening steps. 
The capacity of the bacteria to reduce the given substrate was evaluated using whole cells under growing conditions 
to avoid cofactor recycling and enzyme purification. Cyclohexanone was added to the culture media until the 
bacterial growth had saturated. After 48 h, the formed reaction products were extracted from the culture 
supernatants, and the product profile was analyzed by GC. Fig. 2a shows the bacterial strains that afforded positive 
results. The following microorganisms presented conversions higher than 20% and were selected to perform further 
biotransformations: E. chrysanthemi (CECT 509), E. carotovora (CECT 314), E. carotovora (CECT 225), 
Streptomyces sp. (CECT 3145), and Xanthomonas fragariae (CECT 549). There are some previous reports on the 
use of Erwinia [36], Streptomyces [37], or Xanthomonas [38] for the reduction of different aliphatic ketones or - 
and β-ketoesters, but to the best of our knowledge, there are no reports on the reduction of cyclic ketones using 
these biocatalysts. Moreover, the conversion rates obtained in the present work are relatively high for non-modified 
wild-type microorganisms. 
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3.2. Fungal screening 
With the aim of selecting new fungal biocatalysts with ADH activity, we applied our screening strategy for fungi 
isolated from different food sources. Because many fungal species can grow on amino acids as sole carbon and 
energy source and the complete lysis of their cells is generally not trivial, the methodologies employed in the primary 
and secondary bacterial screening were not feasible. Therefore, only the specific screening step was conducted for 
these microorganisms. To optimize the previously reported methodology [28], different variables such as culture 
age, aeration, initial amount of inoculum, reaction time, and cells state (growing or resting) were evaluated. Mucor 
piriformis (SCR11) was used as a model microorganism in these assays. All the conditions assayed and the results 
are shown in Table 1.  
Because the production of high amounts of Mucor spores was difficult and an increase in the initial inoculum (Table 
1, entries 1 and 2) did not afford any significant conversion improvement, the experiments were continued using 
1x104 spores/mL inoculum. Regarding culture age and reaction time (entries 1, 3, 4, and 5), the highest conversion 
was achieved using 6-day-old pre-grown fungal cultures reacted for 4 days (entry 5). The conversion value 
decreased when aeration was enhanced by performing the biotransformation in baffled Erlenmeyer flasks (entry 6). 
This possibly occurred because of the excess of oxygen in the reaction medium, which shifted the reaction 
equilibrium toward oxidation. A similar conversion drop was observed when resting cells instead of growing cells 
were used as biocatalyst (entry 7).  
Finally, the experimental conditions detailed in entry 5 (Table 1) were used for fungal screening, and the results are 
shown in Fig. 2b. The conversions obtained for most of the fungi assayed were higher than those achieved in our 
bacterial screening (Fig. 2). Most significantly, five of the tested fungi afforded conversions higher than 30%: M. 
racemosus (SCR21, STCC22 and SCG11), M. piriformis (SCR11), and G. candidum (GC1). To the best of our 
knowledge, this is the first time that M. piriformis has been used for cyclohexanone reduction. Additionally, the 
conversion obtained in our work using G. candidum strain GC1 is higher than what has been previously reported 
for other strains of this fungus [39]. 
3.3. Microbial reduction of non-prochiral cyclic ketones 
ADH-catalyzed reduction of exocyclic aromatic ketones, β-ketoesters, or aldehydes [40, 41] have been extensively 
studied, but very few reports deal with cyclic or heterocyclic ketones as substrates of these enzymes. Therefore, 
the 10 strains selected in the specific screening step, including 5 different bacteria and 5 fungi, were used for the 
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reduction of cyclohexanone (1a), tetrahydro-4H-pyran-4-one (2a), tetrahydro-4H-pyran-4-one (3a), and N-Boc-4-
piperidinone (4a) to analyze heteroatom influence. In addition, cyclododecanone (5a) was used for testing steric 
hindrance (Fig. 3).  
As shown in Fig. 4, Streptomyces sp. (CECT 3145) and E. carotovora (CECT 225) were the only bacteria that could 
reduce the carbonyl group in the sulfur-containing cyclic ketone (3a), while almost all fungi afforded good 
conversions for this substrate, reaching approximately 80% in the case of the two M. racemosus strains evaluated. 
In contrast, neither bacteria nor fungi were useful biocatalysts for reducing the oxygenated analogue (2a). When a 
cyclic ketone containing N-Boc (4a) was tested, all the selected biocatalysts could reduce it, with conversions 
between 20-40%. Remarkably M. racemosus (SCG11) achieved conversion values as high as 43% with this 
substrate.  
As mentioned above, the selected biocatalysts reduced (1a) yielding cyclohexanol (1b) between 25% and 70% 
conversion. Substrates possessing sterically demanding groups on each side of the carbinol moiety are, for most 
dehydrogenases, very poor substrates [42]. When using a bulky ketone such as (5a) as substrate, the majority of 
the tested microorganisms could not reduce it. However, E. chrysanthemii (CECT 509) and M. racemosus 
(STCC22) yielded 100% and 93% conversions of (5a) to (5b), respectively. The only previous report regarding 
ADH-biocatalyzed reduction of compound (5a) was published by Carballeira et al. [28]. They used the fungal 
species Absidia glauca, Gongronella butleri, and Pyrenochaeta oryzae, which afforded 87%, 25%, and 41% 
conversion, respectively. To the best of our knowledge, there are no previous reports on bacterial reduction of 
cyclododecanone, which makes the work presented here first of its kind. 
3.4. Microbial reduction of prochiral ketones 
During the past two decades, significant efforts have been devoted to developing efficient scaffolds for the 
construction of chiral organocatalysts [43]. The vast majority of organocatalysts are amine compounds [44], which 
are usually chiral structures that comprise various organic moieties, such as chiral amino alcohols, diamines, 
prolinamides, and their derivatives.  
Thus, we decided to synthesize chiral nitrogen-containing heterocyclic alcohols. Fig. 5 shows the conversion and 
enantiomeric excess obtained from the biocatalytic reduction of N-Boc-3-piperidinone (6a) and N-Boc-3-
pyrrolidinone (7a), affording the last compound, better conversion rate and enantiomeric excess. G. candidum 
(GC1) and X. fragariae (CECT 549) were the best fungal and bacteria biocatalysts for compounds (6a) and (7a), 
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respectively. All the alcohols obtained from these biotransformations were (S)-isomers, which is in agreement with 
previously reported reactions using different biocatalysts, including modified bacteria [45]. 
Finally, considering that optically pure 1-phenylethanol derivatives are important building blocks in the preparation 
of fragrances and drugs, it was of interest to us to analyze the microbiological reduction of acetophenone (8a). The 
(S)-enantiomer is produced by most carbonyl reducing enzymes; therefore, to obtain inverse stereoselectivity, 
different screening and protein engineering strategies have been applied. In this sense, ADHs from Leifsonia sp., 
Pseudomonas sp., and Empedobacter brevis were recently isolated from soil samples [46, 47]. The screening of 
our biocatalyst collection showed that all the microorganisms tested produced the (S)-isomer, as expected, except 
G. candidum (GC1), which yielded the (R)-isomer, showing good enantiomeric excess and conversion rate. This 
fungal species has also been reported to produce (S)-isomer in previous studies [48, 49], making the G. candidum 
strain used in the present work of special interest. For these reasons, we decided to perform a molecular-level 
species identification on G. candidum (GC1). The strain was originally identified at species level according to its 
physio-morphological growth characteristics. DNA-level analysis was performed for re-confirming the taxonomic 
status of the given strain. 
3.5. ITS sequencing results and confirmation of the strain GC1 species identity  
PCR amplification using the primers ITS1/ITS4 resulted in a 372-bp amplicon. The manual analysis of the 
sequencing chromatograms revealed evident intra-genomic nuclear rDNA polymorphism in the strain GC1. This 
was detected as dual peeks specifically within the ITS1 region. Such intra-nuclear rDNA polymorphism has been 
reported before for Galactomyces sp. [50] and was further studied in detail in G. candidus (teleomorph of G. 
candidum) by Alper et al. [51]. Despite the detected dual peeks, the automatized base calling, which reflects the 
dominant bases at multivariable sequence positions, was accepted. However, one nucleotide (polymorphic position 
64) had to be left ambiguous (M=A or C) because of variation in the dominant base-calling results between repeated 
sequencing reactions.  
Blast searches using the final assembled dominant ITS sequence demonstrated that strain GC1 inarguably belongs 
to the fungal complex of G. geotrichum/G. candidus (99-98% sequence identity). Current species nomenclature 
accepted by NCBI taxonomy browser considers these two taxa as one, under the anamorphic species name G. 
candidum. Accordingly, the ITS sequence, deposited under GenBank accession no. KY009607, is now linked to G. 
candidum as source organism. 
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The taxonomic revision of Geotrichum and its teleomorphs by de Hoog and Smith [50] has proposed a division of 
the G. geotrichum/G. candidus complex into four independent species: G. geotrichum, G. candidus, G. 
pseudocandidus sp. nov., and G. europaeum sp. nov. 
G. candidum would be the anamorphic state linked to G. candidus, while the anamorph of G. geotrichum remains 
taxonomically unidentified. More importantly, these two Galactomyces sibling species cannot be identified using 
molecular taxonomy tools, such as ITS sequencing. Nonetheless, according to the Galactomyces sp. identification 
key by de Hoog & Smith [52], these closely related species can be distinguished by further growth phenotypic 
testing. This involves differential temperature tolerance, G. candidus being able to grow at 35°C, while G. 
geotrichum does not present growth at such an elevated temperature.  
The growth capacity of the strain GC1 was tested at this restrictive temperature on solid 2% malt extract media. No 
growth was detected after 1 week of cultivation, which strongly suggests that according to Galactomyces sp. 
definition key established by de Hoog & Smith [52], the tested GC1 is a strain of G. geotrichum.  
Presently, G. geotrichum does not have independent species status. Under official species nomenclature 
(http://www.catalogueoflife.org/), G. geotrichum and G. candidus are considered synonymous names, which 
actually refer to Dipodascus geotrichum (E.E. Butler & L.J. Petersen) Arx, 1977, the officially accepted and oldest 
scientific species name of the given fungal taxon. 
4. Conclusions 
There are no existing reports on the use of hierarchical screening approach to detect the reduction capacity of 
heterocyclic ketones among wild-type bacteria and fungi. According to our results, the tested fungal species were 
more efficient biocatalysts than the bacteria. However, while fungi are the most widespread source of 
oxidoreductases, the main disadvantage of using wild-type fungal cells instead of bacterial ones at a preparative 
scale is the downstream processing steps that are required [53].  
Although the heteroatom present in the cyclic ketones did not significantly affect reaction conversions, general 
trends were observed: oxygen replacement afforded lower conversions and bacteria showed lower acceptance of 
sulfur-containing heterocycles than fungi. 
Each microorganism selected on the basis of the results of our specific screening step showed relevant 
characteristics as a biocatalyst. E. chrysanthemi (CECT 509) and M. racemosus (STCC22) could reduce a bulky 
ketone with very high efficiency, resulting in substrate conversions of 100% and 93%, respectively. G. candidum 
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(GC1), E. carotovora (CECT 225), and X. fragariae (CECT 549) resulted in good conversions and enantiomeric 
excess for prochiral ketone substrates; E. carotovora (CECT 225) afforded (S)-N-Boc-3-pyrrolidinol with 87% 
conversion and more than 99%ee, and X. fragariae (CECT 549) quantitatively generated (S)-1-phenylethanol with 
79%ee. Finally, G. candidum (GC1) reduced all prochiral ketones tested in our study. Most importantly, this strain 
of the fungus reduced acetophenone and resulted in the anti-Prelog isomer, making it of special interest for further 
studies and applications. 
Moreover, the use of recombinant microorganisms that overexpress highly active reductases may lead to greater 
productivity. Therefore, enzyme overexpression of the most interesting biocatalysts identified in this study is 
currently in progress. 
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Figure captions 
Fig 1 General scheme of enzymatic reduction of (hetero)cyclic ketones. X=CH2, S, N-Boc, O; n=0, 1, 7 
Fig 2 Specific screening results. Biocatalyzed reduction of cyclohexanone to cyclohexanol by (a) bacterial and (b) 
fungal strains under growing conditions. Conversions determined by GC 
Fig 3 (Hetero)cyclic ketones used as substrates. (1a) cyclohexanone, (2a) tetrahydro-4H-pyran-4-one, (3a) 
tetrahydro-4H-pyran-4-one, (4a) N-Boc-4-piperidone, (5a) cyclododecanone, (6a) N-Boc-3-piperidone, (7a) N-Boc-
3-pyrrolidinone 
Fig 4 Biocatalyzed reduction of non-prochiral (hetero)cyclic ketones. Biotransformations were carried out using 
microorganisms selected in the specific screening. Conversions were determined by GC. (1b) cyclohexanol, (2b) 
tetrahydro-4H-pyran-4-ol, (3b) tetrahydro-4H-pyran-4-ol, (4b) N-Boc-4-piperidinol, (5b) cyclododecanol 
Fig 5 Biocatalyzed reduction of prochiral ketones. Biotransformations were carried out using microorganisms 
selected in the specific screening. Conversions were determined by GC. %ee (expressed inside square brackets) 
was obtained from chiral GC and confirmed against standard samples. (6b) N-Boc-3-piperidinol, (7b) N-Boc-3-
pyrrolidinol, (8b) 1-phenylethanol. 
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Table 1. Reduction of cyclohexanone to cyclohexanol biocatalyzed by Mucor piriformis (SCR11).  
Optimization of the experimental conditions used in fungal screening. Conversions were determined by 
GC 
Entry 
Culture age 
(days) 
Reaction 
time 
(days) 
Initial 
inoculum 
(x104 
spores/mL) 
Aeration Cell state# 
Cyclohexanol 
conversion (%) 
1 3 3 1 No G 25 
2 3 3 7.5 No G 28 
3 3 4 1 No G 27 
4 6 3 1 No G 29 
5 6 4 1 No G 39 
6 6 4 1 Yes G 16 
7 6 4 1 No R 12 
# G: growing; R: resting 
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